rs145300245

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003611.3(OFD1):​c.1923G>A​(p.Glu641Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.00455 in 1,207,779 control chromosomes in the GnomAD database, including 9 homozygotes. There are 1,687 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., 80 hem., cov: 23)
Exomes 𝑓: 0.0047 ( 8 hom. 1607 hem. )

Consequence

OFD1
NM_003611.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.95

Publications

1 publications found
Variant links:
Genes affected
OFD1 (HGNC:2567): (OFD1 centriole and centriolar satellite protein) This gene is located on the X chromosome and encodes a centrosomal protein. A knockout mouse model has been used to study the effect of mutations in this gene. The mouse gene is also located on the X chromosome, however, unlike the human gene it is not subject to X inactivation. Mutations in this gene are associated with oral-facial-digital syndrome type I and Simpson-Golabi-Behmel syndrome type 2. Many pseudogenes have been identified; a single pseudogene is found on chromosome 5 while as many as fifteen have been found on the Y chromosome. [provided by RefSeq, Aug 2016]
OFD1 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 10
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • orofaciodigital syndrome I
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa 23
    Inheritance: XL Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Simpson-Golabi-Behmel syndrome type 2
    Inheritance: XL Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant X-13760383-G-A is Benign according to our data. Variant chrX-13760383-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 41088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00291 (326/111975) while in subpopulation NFE AF = 0.00504 (268/53191). AF 95% confidence interval is 0.00454. There are 1 homozygotes in GnomAd4. There are 80 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 80 XL,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OFD1NM_003611.3 linkc.1923G>A p.Glu641Glu synonymous_variant Exon 16 of 23 ENST00000340096.11 NP_003602.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OFD1ENST00000340096.11 linkc.1923G>A p.Glu641Glu synonymous_variant Exon 16 of 23 1 NM_003611.3 ENSP00000344314.6

Frequencies

GnomAD3 genomes
AF:
0.00291
AC:
326
AN:
111924
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000390
Gnomad AMI
AF:
0.0293
Gnomad AMR
AF:
0.00132
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00149
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00504
Gnomad OTH
AF:
0.00202
GnomAD2 exomes
AF:
0.00282
AC:
513
AN:
182056
AF XY:
0.00281
show subpopulations
Gnomad AFR exome
AF:
0.000457
Gnomad AMR exome
AF:
0.000515
Gnomad ASJ exome
AF:
0.000136
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00113
Gnomad NFE exome
AF:
0.00573
Gnomad OTH exome
AF:
0.00179
GnomAD4 exome
AF:
0.00472
AC:
5169
AN:
1095804
Hom.:
8
Cov.:
32
AF XY:
0.00445
AC XY:
1607
AN XY:
361528
show subpopulations
African (AFR)
AF:
0.000533
AC:
14
AN:
26279
American (AMR)
AF:
0.000543
AC:
19
AN:
34986
Ashkenazi Jewish (ASJ)
AF:
0.000156
AC:
3
AN:
19292
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30173
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
53947
European-Finnish (FIN)
AF:
0.00123
AC:
50
AN:
40498
Middle Eastern (MID)
AF:
0.000497
AC:
2
AN:
4025
European-Non Finnish (NFE)
AF:
0.00587
AC:
4931
AN:
840644
Other (OTH)
AF:
0.00324
AC:
149
AN:
45960
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
211
421
632
842
1053
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00291
AC:
326
AN:
111975
Hom.:
1
Cov.:
23
AF XY:
0.00234
AC XY:
80
AN XY:
34143
show subpopulations
African (AFR)
AF:
0.000389
AC:
12
AN:
30809
American (AMR)
AF:
0.00132
AC:
14
AN:
10628
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2643
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3563
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2703
European-Finnish (FIN)
AF:
0.00149
AC:
9
AN:
6030
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.00504
AC:
268
AN:
53191
Other (OTH)
AF:
0.00199
AC:
3
AN:
1507
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00313
Hom.:
27
Bravo
AF:
0.00276
EpiCase
AF:
0.00464
EpiControl
AF:
0.00558

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Oct 21, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 02, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 18, 2016
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Sep 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 18546297) -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Joubert syndrome;C1510460:Orofaciodigital syndrome I Benign:1
Jan 22, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia Benign:1
Feb 07, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Retinitis pigmentosa 23;C1510460:Orofaciodigital syndrome I;C1846175:Simpson-Golabi-Behmel syndrome type 2;C2749019:Joubert syndrome 10 Benign:1
Aug 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
3.9
DANN
Benign
0.40
PhyloP100
4.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145300245; hg19: chrX-13778502; COSMIC: COSV60797781; COSMIC: COSV60797781; API